Skip to main content
. 2018 Apr 6;9(6):707–717. doi: 10.1111/1759-7714.12636

Figure 5.

Figure 5

Changing trends of neoadjuvant chemotherapy administration by lymph node involvement/metastatic cancer status for breast cancer from 2006 to 2015. (Inline graphic) Neither, (Inline graphic) only lymph node involvement, (Inline graphic) only metastatic tumors, (Inline graphic) both, and (Inline graphic) overall.